MARCKS inhibitors (University of California Davis)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameMARCKS inhibitors (University of California Davis)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionMyristoylated alanine-rich C-kinase substrate inhibitors
TargetsMyristoylated alanine-rich C-kinase substrate
Therapy Area/IndicationsAsthmaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of California Davis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of California Davis
Active IndicationsN/A
Inactive IndicationsAsthmaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A